FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:664-665 August 26, 1993 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Shivdasani, R. A.

To the Editor: In their discussion of graft-versus-host disease (GVHD) associated with the transfusion of blood from unrelated HLA-homozygous donors, Shivdasani et al. (March 18 issue)¹ cite data indicating that the risk of transfusion of blood from HLA homozygotes to HLA heterozygotes with a shared haplotype is 1 in 7174 among whites in the United States². They misinterpret this to mean that the incidence of transfusion-associated GVHD "may be as high as 1 in 7174 among whites." If this were true, more than 1500 cases would occur in immunocompetent patients each year in the United States, since more than . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.